Klotho Neurosciences (KLTOW) Stock Analysis

What Klotho Neurosciences does

Klotho Neurosciences, Inc. is a biopharmaceutical company focused on developing medical treatments for a variety of severe illnesses, including cancer, heart disease, and conditions affecting the nervous system. Among its key product initiatives are gene therapy candidates: AMI-101, designed for either preventing or treating Alzheimer's disease, and AMI-202, intended to manage and prevent amyotrophic lateral sclerosis (ALS). The company, situated in Omaha, Nebraska, changed its corporate identity to Klotho Neurosciences, Inc. in September 2024, having previously been known as Anew Medical, Inc.

Key metrics

ETFs linked to KLTOW

Broad-market and Healthcare sector ETFs an investor holding Klotho Neurosciences is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how KLTOW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Klotho Neurosciences?

Klotho Neurosciences trades under the ticker KLTOW on NASDAQ.

Which exchange is KLTOW listed on?

KLTOW is listed on NASDAQ.

What sector does Klotho Neurosciences operate in?

Klotho Neurosciences is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze KLTOW in a portfolio?

PortView shows KLTOW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.